• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Annexon, Inc. - common stock (NQ:ANNX)

    2.680 -0.160 (-5.63%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,852,877
    Open 2.570
    Bid (Size) 2.600 (800)
    Ask (Size) 2.960 (300)
    Prev. Close 2.840
    Today's Range 2.540 - 2.830
    52wk Range 1.285 - 6.930
    Shares Outstanding 47,722,995
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    From Annexon Biosciences
    Via GlobeNewswire

    Performance

    YTD
    -51.3%
    -51.3%
    1 Month
    -10.8%
    -10.8%
    3 Month
    +3.1%
    +3.1%
    6 Month
    +52.3%
    +52.3%
    1 Year
    -59.5%
    -59.5%

    More News

    Read More
    News headline image
    Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Biosciences to Participate in Upcoming September Investor Conferences
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Narrows Loss in Fiscal Q2 ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Annexon Reports Second Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Thursday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
    Via Benzinga
    News headline image
    Stanley Black & Decker To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
    Via Benzinga
    News headline image
    Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon's Investigational Drug Shows Rapid Recovery And Durable Benefit In Rare Neurological Disorder ↗
    Via Benzinga
    News headline image
    Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Annexon, Inc. - common stock publicly traded?
    Yes, Annexon, Inc. - common stock is publicly traded.
    What exchange does Annexon, Inc. - common stock trade on?
    Annexon, Inc. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Annexon, Inc. - common stock?
    The ticker symbol for Annexon, Inc. - common stock is ANNX on the Nasdaq Stock Market
    What is the current price of Annexon, Inc. - common stock?
    The current price of Annexon, Inc. - common stock is 2.680
    When was Annexon, Inc. - common stock last traded?
    The last trade of Annexon, Inc. - common stock was at 11/13/25 04:00 PM ET
    What is the market capitalization of Annexon, Inc. - common stock?
    The market capitalization of Annexon, Inc. - common stock is 127.90M
    How many shares of Annexon, Inc. - common stock are outstanding?
    Annexon, Inc. - common stock has 128M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.